Active10227584Private limited companyLondon

ELEUSIS THERAPEUTICS LTD

Significant control: Eleusis Therapeutics Holdings Ltd (75–100%)

Companies HouseCompanies House

From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms

Watch this company

Get an email when Companies House records a change for Eleusis Therapeutics Ltd: status, filings, accounts, officers or owners. Free.

Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy

Coming soon · product and service lists

What does Eleusis Therapeutics Ltd sell?

Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.

One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy
01

Summary

Generated from filed data · no estimates

ELEUSIS THERAPEUTICS LTD is an active private limited company (company number 10227584) incorporated on 12 June 2016, registered in London. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest small accounts cover the period ending 31 December 2024, showing net assets of −£11.08m and cash of £70k, with 5 employees on average. Net assets fell 21% on the prior period (−£9.14m).

Peer position · net assets

By net assets it sits in the bottom quarter of 603 comparable companies in London (median £440, upper quartile £92k).

02

Ownership and control

1 active · 2 other
  • Eleusis Therapeutics Holdings Ltd
    corporate entity, England And Wales · since 2 June 2020
    • owns 75–100% of shares
    • holds 75–100% of voting rights
    • can appoint or remove directors
  • Eleusis Interim Holdings Ltd
    corporate entity, United Kingdom · since 12 June 2016 · ceased 10 July 2017
    • owns 75–100% of shares
    • holds 75–100% of voting rights
    • can appoint or remove directors
  • Eleusis Holdings Limited
    corporate entity, United Kingdom · since 10 July 2017 · ceased 2 June 2020
    • owns 75–100% of shares
    • holds 75–100% of voting rights
    • can appoint or remove directors

Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.

03

Key dates

Incorporated
12 June 201610 yrs ago
Next accounts due
30 September 202628 days overdue
Confirmation statement due
26 June 2027in 241 days

Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.

04

Activity

SIC 72110
Research and experimental development on biotechnology
Accounts type
Total Exemption Full
Size band
MicroCompanies Act thresholds
05

Financials

2 periods on record · latest ending 31 December 2024
Net assets
−£11.08m
vs Dec 2023
Cash at bank
£70k
+365%vs Dec 2023
Turnover
Not reported
Employees
5
−29%vs Dec 2023
Net assets
−£11.08m
Cash at bank
£70k
Average employees
5
Filed accounts by period, newest first
Period endNet assetsCashDebtorsCreditors <1yTurnoverProfitEmployees
31 December 2024−£11.08m£70k£1.75m———5
31 December 2023−£9.14m£15k£2.43m———7
Cash per employee£14kCash ÷ average employees

Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.

06

Filing and accounts signals

Facts from the register · no rating
  • Net assets below zeroNet assets £-11,075,070 at 31 December 2024
  • Cash at bank of £50,000 or moreCash £69,559
  • Incorporated five or more years agoIncorporated 12 June 2016
  • Accounts past their due dateDue 30 September 2026

Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.

07

Timeline

Newest first
  1. Confirmation statement duein 241 days
  2. Next accounts due28 days overdue
  3. Accounts period endNet liabilities £11.08m · small accounts
  4. Accounts period endNet liabilities £9.14m · small accounts
  5. Incorporated
08

Similar companies in London

Same activity (research and experimental development on biotechnology), closest in incorporation date
09

Reminders for ELEUSIS THERAPEUTICS LTD

Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.

Source: Companies House register, snapshot 2026-08-31; accounts from the Companies House accounts data product. Open Government Licence v3.0. View on Companies House. Methodology · About · Markdown. Contact us about this company.